Cite

HARVARD Citation

    Nahass, R. et al. (n.d.). 818Safety of ABT-450/r/Ombitasvir + Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients, by Baseline Demographics. Open forum infectious diseases. pp. S232-S233. [Online]. 
  
Back to record